3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER
3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER Basic information
- Product Name:
- 3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER
- Synonyms:
-
- 3-(3-bromophenyl)-3-keto-propionic acid ethyl ester
- ETHYL 3-(3-BROMOPHENYL)-3-OXOPROPANOATE
- ETHYL (3-BROMOBENZOYL)ACETATE
- 3-Bromo--oxo-benzenepropanoic acid ethyl ester
- 2-[(3-bromophenyl)-oxomethyl]butanoate
- Ethyl (3-bromobenzoyl)acetate 95%
- 3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER
- Benzenepropanoic acid,3-bromo-b-oxo-, ethyl ester
- CAS:
- 21575-91-7
- MF:
- C11H11BrO3
- MW:
- 271.11
- Product Categories:
-
- C10 to C11
- Carbonyl Compounds
- Esters
- Mol File:
- 21575-91-7.mol
3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER Chemical Properties
- Boiling point:
- 255-256 °C(lit.)
- Density
- 1.416 g/mL at 25 °C(lit.)
- refractive index
- n20/D 1.565(lit.)
- Flash point:
- >230 °F
- storage temp.
- Sealed in dry,Room Temperature
- pka
- 9.91±0.46(Predicted)
- Appearance
- Light brown to reddish brown Liquid
- CAS DataBase Reference
- 21575-91-7(CAS DataBase Reference)
MSDS
- Language:English Provider:SigmaAldrich
3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER Usage And Synthesis
Uses
Reactant involved in synthesis of:
- Aroylbenzoxepinones for analgesic activity
- (Heteroaryl)(carboxamido)arylpyrrole derivatives with Cdc7 kinase inhibitory activity
- Cambinol analogs for sirtuin inhibition and antitumor activity
- TunePhos-type diphosphine ligands via asymmetric hydrogenation
Synthesis
24398-88-7
141-78-6
21575-91-7
A solution of 1.3 M LHMDS (25 mL, 32.7 mmol) in THF (10 mL) was stirred at -78 °C and under an inert atmosphere, and ethyl acetate (1.9 g, 21.8 mmol) was added slowly. After stirring for 15 min, ethyl 3-bromobenzoate (5 g, 21.8 mmol) was added and stirring was continued for 2 hours. The reaction progress was monitored by TLC. Upon completion of the reaction, the reaction was quenched with 10 mL of saturated aqueous NH4Cl and extracted with ethyl acetate (3 x 20 mL). The organic phases were combined, dried with anhydrous Na2SO4 and concentrated under reduced pressure to obtain the crude product. The crude product was purified by silica gel column chromatography with 4% ethyl acetate/hexane as eluent to afford the target compound, ethyl 3-bromobenzoylacetate (4.5 g, 76.9%) as a mixture of enol forms in the form of a brown oil.1H NMR (500 MHz, CDCl3): δ 8.07 (s, 1H), 7.86 (d, J=7.5 Hz, 1H), 7.73 -7.69 (m, 1H), 7.37 (t, J=7.0Hz, 1H), 4.28-4.26 (m, 2H), 3.92 (s, 2H), 1.24 (t, J=6.2Hz, 3H).MS (ESI): m/z 298.8 [M-1].
References
[1] Patent: WO2015/191630, 2015, A1. Location in patent: Paragraph 00457
[2] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 13, p. 2991 - 3013
3-(3-BROMO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTERSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com
- Tel
- 021-50795510 4000665055
- sales@accelachem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 028-85114309 18982182443
- yangli@happysyn.com